GOL (13.125 gm+350.7 mg+178.5 mg+46.6 mg)/25 ml (Oral Solution)
100 ml bottle: ৳ 160.00
Medicine Details
Category | Details |
---|---|
Generic | Polyethylene glycol 3350 electrolytes |
Company | Square pharmaceuticals plc |
Title
- GOL Concentrated Oral Solution
Categories
- Medicine
- Laxative
- Gastrointestinal Health
- Medication
Description
- Effective relief from constipation
- Treatment of chronic constipation
- Resolution of fecal impaction
- Osmotic action in the gut
- Increases stool volume
- Triggers colon motility
- No net gain or loss of sodium, potassium and water
- Virtually unabsorbed from the gastrointestinal tract
- For adults and children over 12 years of age
- Therapeutic Class: Osmotic purgatives
Dimensions
- 25 ml
- Sachet
Color Options
Functions
- Laxative effect
- Improved propulsive colonic transportation
- Facilitation of defecation
Materials
- Polyethylene Glycol 3350
- Sodium Chloride
- Sodium Bicarbonate
- Potassium Chloride
Technical Specifications
- Each 25 ml concentrated oral solution contains-
- Each sachet (Powder for Suspension) contains-
Design Elements
Usability Features
Dosage & Administration
- For adults and children aged 12 years and above
- 1 sachet daily for constipation
- 8 sachets daily for fecal impaction
- Contains instructions for patients with renal insufficiency
- Oral solution can be added to water for consumption
- Dissolution instructions provided
- Direction of use for various conditions
- Store the solution refrigerated and discard any solution not used within 6 hours
Interaction
- Possible transient reduction in absorption of other medicinal products
- Decreased efficacy with some concomitantly administered medicinal products
Contraindications
- Intestinal perforation or obstruction
- Severe inflammatory conditions of the intestinal tract
- Toxic megacolon
- Hypersensitivity to the active substances
Side Effects
- Allergic reactions
- Electrolyte disturbances
- Abdominal pain
- Diarrhea
- Headache
- Peripheral edema
Pregnancy & Lactation
- Clinically no effects anticipated during pregnancy
- Safe for use during pregnancy
- Safe for use during breastfeeding
- No effects on the breastfed newborn/infant anticipated
Precautions & Warnings
- Patients with impaired cardiovascular function should divide the dose
- Monitoring symptoms indicating shifts of fluid/electrolytes
- Prolonged use may lead to dependence
Overdose Effects
- Severe pain or distention
- Extensive fluid loss by diarrhea or vomiting may require correction of electrolyte disturbances
Storage Conditions
- Store below 30°C
- Place protected from light
- Do not refrigerate
Related Brands
- Movicol (13.125 gm+350.7 mg+178.5 mg+46.6 mg)/25 ml (Oral Solution) - mundipharma-bd-pvt-ltd
- Macrosol (13.125 gm+350.7 mg+178.5 mg+46.6 mg)/25 ml (Oral Solution) - popular-pharmaceuticals-ltd
- Macolax (13.125 gm+350.7 mg+178.5 mg+46.6 mg)/25 ml (Oral Solution) - opsonin-pharma-ltd
- Movifast (13.125 gm+350.7 mg+178.5 mg+46.6 mg)/25 ml (Oral Solution) - ziska-pharmaceuticals-ltd
- Movicol (13.125 gm+350.7 mg+178.5 mg+46.6 mg)/sachet (Oral Powder) - mundipharma-bd-pvt-ltd